A Study in Healthy Men to Measure the Amount of BI 425809 in the Blood When Taken as a Tablet
Clinical trial NCT03783000 · COMPLETED
Trial details
- NCT number
- NCT03783000
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-15
- Primary completion
- 2019-03-06
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.